No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
FMS240517C20000
- 0.98
- -0.02-2.00%
15min DelayClose May 8 15:59 ET
0.98High0.80Low
0.80Open1.00Pre Close3 Volume130 Open Interest20.00Strike Price273.00Turnover65.81%IV2.76%PremiumMay 17, 2024Expiry Date0.68Intrinsic Value100Multiplier9DDays to Expiry0.30Time Value100Contract SizeAmericanOptions Type0.6494Delta0.1708Gamma16.54Leverage Ratio-0.0462Theta0.0031Rho10.74Eff Leverage0.0122Vega
Intraday
- 5D
- 1D
News
Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) Q1 2024 Earnings Call Transcript
European Equities Traded in the US as American Depositary Receipts Trend Modestly Higher in Wednesday Trading
European equities traded in the US as American depositary receipts were trending modestly higher late Wednesday morning, rising 0.34% to 1,399.71 on the S&P Europe Select ADR Index. From continental E
Fresenius's Exit of Vamed Business Is a Positive -- Market Talk
0944 GMT - Fresenius's initiation to exit its Vamed business, seen as a drag on profitability, should be welcomed by investors, Berenberg analysts say in a note. The analysts estimate that the divestm
Analysts' Top Healthcare Picks: Fresenius Medical Care AG & Co. KGaA (GB:0H9X), Omega Therapeutics (OMGA)
Correction to Fresenius Medical Care Article on Tuesday
Fresenius Medical Care reported results for the first quarter. "Fresenius Medical Care Shares Drop on Profit Fall," at 0855 GMT on Tuesday, misstated the company name in the third paragraph.
Fresenius Shares Rise After Guidance Lift, Vamed Exit
By Helena Smolak Fresenius shares rose after the company lifted its full-year guidance on rising first-quarter net profit that beat expectations and said it started the exit from its investment compa
Comments
Michael Sen and Helen Giza show confidence in Cordola's leadership for Care Delivery due to his extensive experience. They believe he'll be crucial for Fresenius Medical Care's ongoing transformation focusing on patient care.
Press Release: Fresenius Medical Care Appoints Craig Cordola as New Management Board Member for Care Delivery
ColumnsNovo Nordisk Sets New Record High: Analyzing the Market Effects of Popular GLP-1 Weight Loss Drugs
The increasing demand for GLP-1 weight-loss medications indicates that in the next ten years, a significant number of Americans may lose hundreds of millions of pounds collectively. This shift in weight could cause a redistribution of trillions of dollars.
Last week, $Novo-Nordisk A/S(NVO.US$ presented evidence of a speeding trend when it announced that the primary component of Ozempic and Wegovy, ...
Last week, $Novo-Nordisk A/S(NVO.US$ presented evidence of a speeding trend when it announced that the primary component of Ozempic and Wegovy, ...
16
Weight loss drugs lead the stock market
As GLP-1 diet drug companies have grown in influence, they have grown to be the new leaders of the stock market.
$Novo-Nordisk A/S(NVO.US$ , with Wegovy and Ozempic in hand, is now Europe's largest company with a market capitalization of $433 billion, and the Danish drug giant's rapid growth has even had a direct impact on the Danish krone exchange rate and interest rates.![]()
Meanwhile, $Eli Lilly and Co(LLY.US$ , whic...
As GLP-1 diet drug companies have grown in influence, they have grown to be the new leaders of the stock market.
$Novo-Nordisk A/S(NVO.US$ , with Wegovy and Ozempic in hand, is now Europe's largest company with a market capitalization of $433 billion, and the Danish drug giant's rapid growth has even had a direct impact on the Danish krone exchange rate and interest rates.
Meanwhile, $Eli Lilly and Co(LLY.US$ , whic...
5
Drugs used for weight loss like Ozempic pose a real risk to companies ranging from fast food restaurants to cigarette makers. Expect management teams of public companies to talk about them in their earnings calls.
Ozempic and Wegovy, two weight-loss medications, function by simulating the hormone that signals to people's brains when they are not hungry. Recent anecdotal data indicates that the medicine might reduce users' craving...
Ozempic and Wegovy, two weight-loss medications, function by simulating the hormone that signals to people's brains when they are not hungry. Recent anecdotal data indicates that the medicine might reduce users' craving...
11
1
MACRO
Waller Says Fed 'Finally' Getting Good Inflation Data
"In the last few months, we are finally getting very good inflation data that we wanted." Federal Reserve Governor Christopher Waller says at the annual E2 Summit in Park City, Utah. "If this continues, we're back to our target."
U.S. Stocks Trade Mixed After Fed Minutes, Wholesale Inflation Data
U.S. stocks were trading mixed Wednesday afternoon after the Federal ...
Waller Says Fed 'Finally' Getting Good Inflation Data
"In the last few months, we are finally getting very good inflation data that we wanted." Federal Reserve Governor Christopher Waller says at the annual E2 Summit in Park City, Utah. "If this continues, we're back to our target."
U.S. Stocks Trade Mixed After Fed Minutes, Wholesale Inflation Data
U.S. stocks were trading mixed Wednesday afternoon after the Federal ...
25
5
Read more